Information  X 
Enter a valid email address

Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC

By BFN News | 08:00 AM | Wednesday 22 January, 2020

Liberum Capital today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8810p (from 8300p). Story provided by Broker Forecasts data provided by

a d v e r t i s e m e n t